Analysts Issue Forecasts for PLX Q1 Earnings
Protalix BioTherapeutics, Inc. (NYSE:PLX – Free Report) – Analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for shares of Protalix BioTherapeutics in a research report issued on Friday, May 23rd. HC Wainwright analyst R. Selvaraju forecasts that the company will earn $0.09 per share for the quarter. HC Wainwright has […]
